haEmatology and oncology
ESTRO 38 : Targeting optimal care , together
On behalf of the ESTRO Scientific Advisory Group , it is our honour and pleasure to invite you to ESTRO 38 , the annual congress of ESTRO , that will take place 26 – 30 April 2019 in Milan , Italy
Umberto Ricardi MD Chair , ESTRO 38 , University of Turin , Italy
ESTRO 38 will offer to us all , as professionals of oncology , the chance to share knowledge , practice and advances in the field , within the ever warm and dynamic environment of the ESTRO meetings .
‘ Targeting optimal care , together ’ will be the theme of ESTRO 38 and through these few , however impactful words , the Scientific and Organising Committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty . The theme also represents our strength : we are all working towards a common goal for improved patient outcomes , and this will be expressed throughout the scientific programme :
• Targeting : the concept is inherent to the radiation oncology specialty , and certainly well in line with the modern concept of precision medicine .
• Optimal care : the value and the cost for radiotherapy are an inseparable part of the equation for optimal treatment . Although the clinical outcome of our patients is the priority in our daily practice , this cannot happen without common efforts to improve the access to treatment for all cancer patients .
• Together : the radiation oncology community is a mosaic of various stakeholders : medical and scientific communities , industry , national societies as well as oncology organisations , institutes , patients and advocates . We all join forces .
Planned sessions The interdisciplinary component of the scientific programme will include sessions on the following topics :
• Artificial Intelligence in radiation oncology : role and potential
• Radio-immunotherapy
• Adaptive radiotherapy ( ART ) guided by early response ( adapting the adaptive !)
• Adaptive radiotherapy ( ART ): reactive or proactive ?
• MR machines and treatment adaptation
• Clinical trials for particle therapy : which ones to run and how ?
• The DNA damage response with radiotherapy
• Radiotherapy biomarkers : a confluence of imaging , genetics and pathology
• Cardiac substructures and toxicity
• Predictive models of toxicity and big data , big open issues
• The role of hypofractionation in current radiotherapy and its impact in planning
89 HHE 2018 | hospitalhealthcare . com radiotherapy services
• Palliation in radiotherapy – How much is enough ?
• Are adolescents and young adults a specific patient population ?
• Plan of the day . General gains of performing
• Re-irradiation for breast cancer
• Extreme hypofractionation in the treatment of localised prostate cancer
• Radiotherapy in bladder cancer : standard of care and future perspectives
• Which is the best technique for the delivery of APBI ?
• From discovery to cure
• Dose painting – what is the reality ?
• Inflammatory environmental factors and radiation response
• Functional imaging in radiotherapy : from biology to guidance
• Role of ablative treatments in oligometastatic disease .
With symposia , proffered papers sessions and debates , ESTRO 38 will offer ample opportunities to learn about cutting-edge research from leading scientists .
A strong educational platform will also feature worldwide experts who will give pre-meeting courses , teaching lectures , contouring workshops and multidisciplinary tumour boards during five days .
The Young Scientists ’ Track has now become a not to be missed event within the congress with a one-day programme tailored to the young audience . Lectures , symposia and networking opportunities are on the agenda .
ESTRO ’ s annual congresses feature the largest exhibition in radiation oncology in Europe , with an increasing number of exhibitors year after year . Be there and get a chance to meet all the industry leaders show-casing the latest developments in the radiotherapy and oncology fields .
Finally , I ’ m proud to be part of a society that places quality at the heart of all its scientific moves . The state of the art science presented by worldwide participants at the ESTRO annual congresses impresses me each year . Today I ’ m inviting you to take note of the abstract deadline : submit your work by 22 October 2018 and be part of this outstanding scientific programme .
We look forward to welcoming you in elegant and majestic Milan , where we hope you will join us to make ESTRO 38 a memorable event for the radiation oncology community .